These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 3552595)

  • 21. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Wiseman LR; Wagstaff AJ; Brogden RN; Bryson HM
    Drugs; 1995 Jul; 50(1):73-101. PubMed ID: 7588092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple-dose pharmacokinetics of imipenem-cilastatin.
    Drusano GL; Standiford HC; Bustamante C; Forrest A; Rivera G; Leslie J; Tatem B; Delaportas D; MacGregor RR; Schimpff SC
    Antimicrob Agents Chemother; 1984 Nov; 26(5):715-21. PubMed ID: 6595963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetic and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Obata I; Imagawa N; Yokoyama S; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1986 Jun; 39(6):1531-54. PubMed ID: 3463795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
    Gruber WC; Rench MA; Garcia-Prats JA; Edwards MS; Baker CJ
    Antimicrob Agents Chemother; 1985 Apr; 27(4):511-4. PubMed ID: 3859243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic studies of imipenem/cilastatin in elderly patients.
    Finch RG; Craddock C; Kelly J; Deaney NB
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():103-7. PubMed ID: 3469182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem: a new carbapenem antibiotic.
    Lipman B; Neu HC
    Med Clin North Am; 1988 May; 72(3):567-79. PubMed ID: 3280907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Laboratory and clinical studies of imipenem/cilastatin sodium in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1986 Jul; 39(7):1867-78. PubMed ID: 3464783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections].
    Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative review of the carbapenems.
    Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
    Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
    Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H
    Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.
    Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME
    Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
    Baruchel A; Hartmann O; Andremont A; Tancrède C
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
    Brooks RG; McCabe RE; Vosti KL; Remington JS
    Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of imipenem/cilastatin therapy on faecal flora.
    Nord CE; Kager L; Philipson A; Stiernstedt G
    Eur J Clin Microbiol; 1984 Oct; 3(5):475-7. PubMed ID: 6594237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacterial and clinical studies on imipenem/cilastatin sodium in urological infection].
    Goto T; Kawahara M; Sakamoto N; Ohi Y; Nagata S; Yanase I; Hanabusa A; Imamura A; Shimada T; Kawabata T
    Jpn J Antibiot; 1986 Apr; 39(4):996-1006. PubMed ID: 3463772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imipenem/cilastatin: rationale for a fixed combination.
    Norrby SR
    Rev Infect Dis; 1985; 7 Suppl 3():S447-51. PubMed ID: 3863220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of imipenem-cilastatin in serum and tissue.
    Kümmel A; Schlosser V; Petersen E; Daschner FD
    Eur J Clin Microbiol; 1985 Dec; 4(6):609-10. PubMed ID: 3867509
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology].
    Fujimoto H; Ikeda K; Yamamoto K; Taguchi S; Shirakawa K
    Jpn J Antibiot; 1986 Jun; 39(6):1607-11. PubMed ID: 3463801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.